Background Exogenous surfactants to treat respiratory distress syndrome (RDS) are approved for tracheal instillation only; this requires intubation, often followed by positive pressure ventilation to promote distribution. Aerosol delivery offers a safer alternative, but clinical studies have had mix...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!